KOMBIGLYZE - 0003-4222-16 - (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE)

Alphabetical Index


Drug Information of KOMBIGLYZE

Product NDC: 0003-4222
Proprietary Name: KOMBIGLYZE
Non Proprietary Name: SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
Active Ingredient(s): 1000; 2.5    mg/1; mg/1 & nbsp;   SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of KOMBIGLYZE

Product NDC: 0003-4222
Labeler Name: E.R. Squibb & Sons, L.L.C.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA200678
Marketing Category: NDA
Start Marketing Date: 20101105

Package Information of KOMBIGLYZE

Package NDC: 0003-4222-16
Package Description: 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0003-4222-16)

NDC Information of KOMBIGLYZE

NDC Code 0003-4222-16
Proprietary Name KOMBIGLYZE
Package Description 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0003-4222-16)
Product NDC 0003-4222
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20101105
Marketing Category Name NDA
Labeler Name E.R. Squibb & Sons, L.L.C.
Substance Name METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
Strength Number 1000; 2.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient]

Complete Information of KOMBIGLYZE


General Information